710
Participants
Start Date
July 15, 2020
Primary Completion Date
May 29, 2025
Study Completion Date
June 9, 2025
MicroVention Mechanical Thrombectomy Devices as first-line treatment
Patient will be treated with mechanical thrombectomy at the direction of the treating physician
Mt. Sinai Health System, New York
Montefiore, The Bronx
Northshore University Hospital - Northwell, Manhasset
Stony Brook Medicine, Stony Brook
Geisinger, Danville
University of Pennsylvania Health Systems, Philadelphia
University of Maryland, Baltimore
INOVA, Falls Church
Prisma Health Upstate, Greenville
Augusta University, Augusta
Memorial Healthcare System, Hollywood
Tampa General Hospital, Tampa
Semmes Murphy Clinic, Memphis
ProMedica Toledo, Toledo
Cleveland Clinic, Cleveland
University of Cincinnati, Cincinnati
Goodman Campbell Brain and Spine, Carmel
Ascension Borgess, Kalamazoo
University of Michigan Health West, Wyoming
Munson Medical Center, Traverse City
Allina Health (Abbott Northwestern Hospital), Minneapolis
Sanford Medical Center, Sioux Falls
Javon Bea Hospital, Rockford
SSM Health, Bridgeton
Washington University, St Louis
University of Missouri, Columbia
University of Nebraska Medical Center, Omaha
University of Oklahoma Health Science Center, Oklahoma City
UCHealth Memorial, Colorado Springs
Pacific Neuroscience Institute (Providence), Burbank
Kaiser Permanente, Northern California, Redwood City
Mercy San Juan - Dignity Health Research Institute, Carmichael
The Queen's Medical Center, Honolulu
Swedish Health Services, Seattle
Brigham and Women's hospital, Boston
Baystate Medical Center, Springfield
HMH Jersey Shore University Medical Center, Neptune City
Microvention-Terumo, Inc.
INDUSTRY